Skip to main content
. Author manuscript; available in PMC: 2011 Jan 1.
Published in final edited form as: Gastroenterology. 2009 Sep 24;138(1):347–359. doi: 10.1053/j.gastro.2009.09.015

Figure 5. JNK1 promotes hepatic fibrosis.

Figure 5

A.–D. JNK1-deficient (n=10) or control mice (n=7) underwent BDL for 21 days. Hepatic fibrosis was evaluated by Sirius Red staining (A), αSMA immunohistochemistry (B), αSMA immunoblotting (C), and hydroxyproline content (D). E–F. Hepatic injury was quantified by ALT levels (E) and bile infarcts (f) in JNK1-deficient (n=9) and control mice (n=9) five days after BDL. * p<0.05